Schedule 13D ownership disclosure

NEVRO CORP

Common Stock, par value $0.001 per share · CUSIP: 64157F103

Event date: 2025-03-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • GAMCO INVESTORS, INC. ET ALReported CIK 0000807249

    Shares: 0.00 · Class: 0.0%

  • GABELLI FUNDS LLCReported CIK 0001081407

    Shares: 1,322,950.00 · Class: 3.5%

  • GAMCO Asset Management Inc.Reported CIK 0001460612

    Shares: 88,500.00 · Class: 0.2%

  • GABELLI & Co INVESTMENT ADVISERS, INC.Reported CIK 0000932724

    Shares: 712,450.00 · Class: 1.9%

  • GGCP, INC.Reported CIK 0001238894

    Shares: 0.00 · Class: 0.0%

  • Associated Capital Group, Inc.Reported CIK 0001642122

    Shares: 0.00 · Class: 0.0%

  • GABELLI MARIO JReported CIK 0001185533

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000807249-25-000053
Form type
SCHEDULE 13D
Filer
GAMCO INVESTORS, INC. ET AL
CIK
CIK 807249
Filed
Mar 27, 2025
Reporting period
Mar 20, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub